0.00

0.00% +0.00

Vitro Biopharma, Inc. (VTRO)

Overview News Price History Discussions Forecast

Vitro Biopharma, Inc. stock is currently priced at $0.00, with a 24-hour trading volume of 0. It has seen a +0.00% increased in the last 24 hours and a +0.00% rose in the past month. The chart indicates a potential bullish trend, as the stock is below the $0.00 pivot point. If it approaches the $0.00 support level, significant changes may occur.

Previous Close:

$0.00

Open:

24h Volume:

Market Cap:

$N/A

Revenue:

$1.65M

Net Income/Loss:

$-5.91M

P/E Ratio:

0.00

EPS:

-0.1707

Net Cash Flow:

$-3.03M

1W Performance:

+0.00%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$0.00

52W Range:

$0.00

Vitro Biopharma, Inc. Stock (VTRO) Company Profile

Name

Vitro Biopharma, Inc.

Sector

Healthcare (1223)

Industry

Biotechnology (681)

Phone

(720) 859-4120

Address

4621 TECHNOLOGY DRIVE, GOLDEN

Employee

Twitter

Next Earnings Date

Latest SEC Filings

VTRO's Discussions on Twitter

Vitro Biopharma, Inc. Stock (VTRO) Financials Data

Vitro Biopharma, Inc. (VTRO) Revenue 2024

VTRO reported a revenue (TTM) of $1.65 million for the quarter ending July 31, 2023.

Vitro Biopharma, Inc. (VTRO) Net Income 2024

VTRO net income (TTM) was -$5.91 million for the quarter ending July 31, 2023.

Vitro Biopharma, Inc. (VTRO) Cash Flow 2024

VTRO recorded a free cash flow (TTM) of -$3.03 million for the quarter ending July 31, 2023.

Vitro Biopharma, Inc. (VTRO) Earnings per Share 2024

VTRO earnings per share (TTM) was -$0.1707 for the quarter ending July 31, 2023.

Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders. Their goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market.